United States · FDA National Drug Code directory
RISPERIDONE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 87564-013_58b7505e-32cb-ef57-e063-6394a90abca1
- Product NDC
- 87564-013
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- RISPERIDONE
- Labeler
- Amerisyn LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260806
- Source listing expiry
- 20271231
Source-listed ingredients
- RISPERIDONE — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (87564-013-28) · 87564-013-28
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →